Nutrition

G Medical Innovations announces receipt of patent from USPTO for vital signs sensors

Rehovot, Israel, Feb. 13, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical…

2 years ago

Smart for Life to Hold Shareholder Meeting on March 15, 2023

Shareholder Meeting Follows the Company’s Successful Hearing with the Nasdaq Hearings PanelMIAMI, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Smart for…

2 years ago

First Wave BioPharma Chairman and CEO Issues Letter to Stockholders

BOCA RATON, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”),…

2 years ago

Male Plus Is a Libido Enhancer Designed by One of the Health and Wellness Elite

Brand Founder Tim Torfs Has Nearly Two Decades of Experience Ranging Across the Health and Wellness IndustryFort Lauderdale, FL, Feb.…

2 years ago

Male Plus Arouses Attention from Those With ED

Erections Can Be Hard to Maintain. Male Plus Delivers Natural Support.Fort Lauderdale, FL, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Erectile…

2 years ago

Bon Natural Life Limited Announces FY2022 Earnings Release Date and Webcast

Earnings to be released before market opens on Friday, February 10, 2023XIAN, China, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Bon…

2 years ago

QHSLab, Inc. Reiterates its 2022 Projection of a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care

QHSLab reports that commercialization and the path to profitability is in clear sight, which is an unfamiliar acknowledgment for investors…

2 years ago

BioCorRx to Present at Sequire Biotechnology Conference on February 2nd

Presentation on Thursday, February 2, 2023 at 2:00 PM ET ANAHEIM, CA, Jan. 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc.…

2 years ago

Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead Programs Targeting Hypertension and Artery Disease and Novel Partnership-Enabled Business Model

Business combination with Health Sciences Acquisitions Corporation 2, a special purpose acquisition company sponsored by an affiliate of RTW Investments,…

2 years ago

Novozymes delivers historically strong full-year results

Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This…

2 years ago